Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ON-DEMAND WEBINARS
Delve into the art of tailoring the eConsent experience to match your study and patients' specific needs, such as crafting eConsent documents, selecting appropriate delivery models, and more.
Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.
Explore how clinical teams can overcome data access and analysis challenges with real-time workflows, traceable decisions, and flexible analytics to accelerate insights and improve collaboration.
During this fireside chat, data experts from ActiGraph, VivoSense, and Elektra Labs share cautionary tales of data collection gone awry and how the teams found creative solutions for the problems at hand. Panelists recount real life examples of data collection efforts that missed the mark and provide strategies, tools, and guidance to help clinical teams avoid common missteps in the first place.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1482163984_clinical assessments]( "An Expert's View On Choosing And Developing An eCOA Strategy")
An Expert's View On Choosing And Developing An eCOA StrategyDive into the insights from our recent LinkedIn Live discussion where we explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.
-
![data exchange computer networks-GettyImages-1447176632]( "Navigating The Evolving Regulatory And Data Landscape")
Navigating The Evolving Regulatory And Data LandscapeExplore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.
-
![Electronic Healthcare Information Transfer]( "Simplifying The Vineland-3: Assisting Raters, Reducing Burden, And Improving Data Quality")
Simplifying The Vineland-3: Assisting Raters, Reducing Burden, And Improving Data QualityElectronic versions of both Vineland-II and Vineland-3 have been developed with features to improve data accuracy and consistency such as built-in prompts, item-specific scoring guidance, and automated calculations.
-
![Navigate A Path]( "Taking eCOA Technology Deployment Off The Critical Path")
Taking eCOA Technology Deployment Off The Critical PathConsider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
![GettyImages-1170544407 doctor value]( "The False Economy Of Paper Diaries In Clinical Trials")
The False Economy Of Paper Diaries In Clinical TrialsWhile paper diaries may appear cheaper, but there are hidden costs that make a digital eCOA solution much more affordable in your clinical trial.
-
![Five 5]( "5 Ways Lab Data Can Help Commercialize Your Therapy")
5 Ways Lab Data Can Help Commercialize Your TherapyDelve into five pivotal insights for leveraging lab data effectively and the collaboration that accelerated market entry for new therapies while ensuring the needs of targeted populations were met.
-
![Emotions-iStock-471812192]( "The Case For Cognitive Assessments In Phase 1 Clinical Trials")
The Case For Cognitive Assessments In Phase 1 Clinical TrialsRegulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.
-
![Wearables Whitepaper Image]( "How To Optimize Adherence Of Wearables In Your Clinical Research")
How To Optimize Adherence Of Wearables In Your Clinical ResearchLearn about the top three factors to consider when working to maximize protocol adherence and minimize missing data in a technology-enabled clinical trial.
-
![person using ipad iStock-1029343476]( "Re-Consent In Clinical Trials: Streamlining With eConsent")
Re-Consent In Clinical Trials: Streamlining With eConsentDelve into a variety of triggers for initiating re-consent, perspectives of regulators and IRBs regarding the re-consent process, and the role of digital processes in preventing issues related to re-consent.
-
![Health-medicine-GettyImages-1351646522]( "How Health Information Technology Is Transforming Human Lives")
How Health Information Technology Is Transforming Human LivesHere, the authors take a closer look at how these advancements are not just revolutionizing healthcare but also instilling hope for a brighter and healthier future.
